Wang, X., Song, Z., Wang, X., Zhang, H. (2025). Novel triplet combination of orelabrutinib, lenalidomide, and rituximab as frontlinetherapy for mantle cell lymphoma: Final results of polaris multicenter phase II study. Blood. https://doi.org/10.1182/blood-2025-1803